Biomea Fusion, Inc.
Pharmaceutical Preparations · San Carlos, CA, United States
- PrincipalsMichael J.M. HitchcockInterim CEOand 1 more
- CompanyBiomea Fusion, Inc.San Carlos, CA, United States
- Phone line+1 (650) 980-9099General business
Biomea Fusion, Inc. is an SEC-registered Nasdaq-listed company (ticker BMEA) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Chief executive
Michael J.M. HitchcockInterim CEO
Everyone else on file (1)
Rainer M ErdtmannOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Rainer M Erdtmann — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Michael J.M. Hitchcock — Interim CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
InMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capability